Newer rheumatoid arthritis drugs work well in the real world
New Atlas,
They’ve been approved for the US market since 2012, but Janus kinase (JAK) inhibitors are still the new kid on the block in…
Immunology Newsmakers: Merck acquires Prometheus for US$ 10.8 bn; first cell therapy for type 1 diabetes bags FDA nod
PharmaCompass,
Immunology, or the study of diseases caused by disorders of the immune system, is a field that is witnessing breakthroughs, and…
RINVOQ® (upadacitinib) Has Remission Data, With or Without Methotrexate1-3
Rheumatology Advisor,
Over the past decade, the use of targeted therapies has become a staple in the management of rheumatoid arthritis (RA) and…
